Trademark: 88783462
Status Date
Monday, July 4, 2022
Filing Date
Monday, February 3, 2020
Published for Opposition
Tuesday, October 6, 2020
Abandoned Date
Monday, July 4, 2022
5 pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders
Jul 5, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 4, 2022
Abandonment - No Use Statement Filed
Sep 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2021
Sou Extension 2 Granted
Sep 16, 2021
Sou Extension 2 Filed
Sep 16, 2021
Sou Teas Extension Received
May 6, 2021
Notice Of Approval Of Extension Request E-Mailed
May 4, 2021
Sou Extension 1 Granted
May 4, 2021
Sou Extension 1 Filed
May 4, 2021
Sou Teas Extension Received
Dec 1, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 6, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 6, 2020
Published For Opposition
Sep 16, 2020
Notification Of Notice Of Publication E-Mailed
Aug 28, 2020
Approved For Pub - Principal Register
Aug 27, 2020
Teas/Email Correspondence Entered
Aug 27, 2020
Correspondence Received In Law Office
Aug 25, 2020
Assigned To Lie
Aug 4, 2020
Teas Response To Office Action Received
Mar 11, 2020
Notification Of Non-Final Action E-Mailed
Mar 11, 2020
Non-Final Action E-Mailed
Mar 11, 2020
Non-Final Action Written
Mar 11, 2020
Assigned To Examiner
Feb 7, 2020
New Application Office Supplied Data Entered
Feb 6, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
